Labeler
Fresenius Kabi USA, LLC NDC Codes
Fresenius Kabi USA, LLC lists 714 finished drug products in the FDA NDC Directory under NDC labeler codes 63323, 65219, 76045.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Tyenne, Rocuronium, Sodium chloride, Dextrose, Otulfi, ketamine hydrochloride, Sterile Water, Levetiracetam, Cyclophosphamide, Vitalipid N, Ustekinumab-Aauz, Sodium Bicarbonate, ephedrine sulfate, Bomyntra, Succinylcholine Chloride
- Active ingredients
- Tocilizumab, Ustekinumab, Rocuronium bromide, Sodium chloride, Dextrose monohydrate, Phytonadione, Ketamine hydrochloride, Water, Levetiracetam, Denosumab, Cyclophosphamide, Vitamin a palmitate
- NDC labeler codes
- 63323, 65219, 76045
- Strengths (from the 100 most recently listed products)
- Rocuronium bromide 10 mg/mL; Dextrose monohydrate 50 mg/mL; Tocilizumab 162 mg/.9mL; Water 1 mL/mL; Sodium chloride .9 g/100mL; Ustekinumab 45 mg/.5mL; Ustekinumab 90 mg/mL; Ephedrine sulfate 5 mg/mL; Denosumab 70 mg/mL; Succinylcholine chloride dihydrate 20 mg/mL; Diphenhydramine hydrochloride 50 mg/mL; Amiodarone hydrochloride 50 mg/mL; Epinephrine 1 mg/mL; Chlorpromazine hydrochloride 25 mg/mL; Acyclovir sodium 50 mg/mL; Lorazepam 2 mg/mL; Gadobutrol 604.72 mg/mL; Desmopressin acetate 4 ug/mL; Vitamin a palmitate 230 [iU]/mL; Ergocalciferol 40 [iU]/mL
- Dosage forms
- Injection, Solution, Injection, Injection, Solution, Concentrate, Kit, Injection, Powder, For solution, Emulsion, Injection, Emulsion, Injection, Powder, Lyophilized, For solution, Solution
- Routes
- Intravenous, Subcutaneous, Intramuscular, Irrigation, Oral, Epidural, Infiltration, Perineural, Intraocular
- Drug classes (FDA established)
- Osmotic Laxative, Interleukin-6 Receptor Antagonist, Interleukin-12 Antagonist, Interleukin-23 Antagonist, Potassium Salt, Nondepolarizing Neuromuscular Blocker, General Anesthetic, alpha-Adrenergic Agonist, beta-Adrenergic Agonist, Vitamin K, Warfarin Reversal Agent, RANK Ligand Inhibitor, Benzodiazepine, Provitamin D2 Compound, Vitamin A, Norepinephrine Releasing Agent, Depolarizing Neuromuscular Blocker, Histamine-1 Receptor Antagonist, Antiarrhythmic, Catecholamine, Phenothiazine, Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor, Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor, Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor, Opioid Antagonist, Gadolinium-based Contrast Agent, Factor VIII Activator, Vasopressin Analog, alpha-1 Adrenergic Agonist, Vitamin C, Paramagnetic Contrast Agent, Lipoglycopeptide Antibacterial, Heparin Reversal Agent, beta-Adrenergic Blocker, Amide Local Anesthetic, Calcitonin, Antifibrinolytic Agent, Calcium Channel Blocker, Dihydropyridine Calcium Channel Blocker, Proton Pump Inhibitor, Oxytocic, Corticosteroid, Anticholinergic
- HCPCS / J-code
- J3357 — Injection, ustekinumab, for subcutaneous injection, 1 mg, J0897 — Injection, denosumab, 1 mg, J0171 — Injection, adrenalin, epinephrine, 0.1 mg
- Package NDCs
- 108 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Plerixafor | Plerixafor 24 mg/1.2mL | Injection, SolutionSubcutaneous | 65219-284 | 65219-0284-12 | — |
| Carboprost Tromethamine | Carboprost tromethamine 250 ug/mL | Injection, SolutionIntramuscular | 65219-579 | 65219-0579-01 | — |
| Vasopressin | Vasopressin 20 [USP'U]/mL | Injection, SolutionIntravenous | 65219-039 | 65219-0039-01 | — |
| Vasopressin | Vasopressin 20 [USP'U]/mL | Injection, SolutionIntravenous | 63323-930 | 63323-0930-01 | — |
| Gadobutrol | Gadobutrol 604.72 mg/mL | InjectionIntravenous | 65219-281 | 65219-0281-0265219-0281-0765219-0281-10+1 more | — |
| Sincalide | Sincalide 5 ug/5mL | Injection, Powder, Lyophilized, For solutionIntravenous | 63323-579 | 63323-0579-05 | — |
| Ganirelix Acetate | Ganirelix acetate 250 ug/.5mL | InjectionSubcutaneous | 65219-028 | 65219-0028-05 | — |
| Piperacillin and Tazobactam | Piperacillin sodium 2 g/10mL; Tazobactam sodium .25 g/10mL | Injection, Powder, Lyophilized, For solutionIntravenous | 65219-434 | 65219-0434-20 | — |
| Piperacillin and Tazobactam | Piperacillin sodium 3 g/15mL; Tazobactam sodium .375 g/15mL | Injection, Powder, Lyophilized, For solutionIntravenous | 65219-436 | 65219-0436-20 | — |
| Mitomycin | Mitomycin 5 mg/10mL | Injection, Powder, Lyophilized, For solutionIntravenous | 65219-564 | 65219-0564-20 | — |
| Mitomycin | Mitomycin 20 mg/40mL | Injection, Powder, Lyophilized, For solutionIntravenous | 65219-566 | 65219-0566-20 | — |
| Mitomycin | Mitomycin 40 mg/80mL | Injection, Powder, Lyophilized, For solutionIntravenous | 65219-568 | 65219-0568-00 | — |
| Zinc Sulfate | Zinc sulfate 1 mg/mL | Injection, SolutionIntravenous | 65219-401 | 65219-0401-01 | — |
| Zinc Sulfate | Zinc sulfate 3 mg/mL | Injection, SolutionIntravenous | 65219-403 | 65219-0403-03 | — |
| Zinc Sulfate | Zinc sulfate 5 mg/mL | Injection, SolutionIntravenous | 65219-405 | 65219-0405-05 | — |
| Pralatrexate | Pralatrexate 20 mg/mL | InjectionIntravenous | 65219-550 | 65219-0550-01 | — |
| Pralatrexate | Pralatrexate 40 mg/2mL | InjectionIntravenous | 65219-552 | 65219-0552-02 | — |
| Diazepam | Diazepam 10 mg/2mL | Injection, SolutionIntramuscular, Intravenous | 76045-204 | 76045-0204-20 | — |
| Stimufendpegflilgrastim-fpgk | Pegfilgrastim 6 mg/.6mL | Injection, SolutionSubcutaneous | 65219-371 | 65219-0371-10 | J2506 |
| Bumetanide | Bumetanide .25 mg/mL | InjectionIntramuscular, Intravenous | 65219-570 | 65219-0570-04 | — |
| Bumetanide | Bumetanide .25 mg/mL | InjectionIntramuscular, Intravenous | 65219-572 | 65219-0572-10 | — |
| Potassium Chloride in Dextrose and Sodium Chloridedextrose monohydrate, sodium chloride, and potassium chloride | Dextrose monohydrate 50 g/1000mL + 2 more ingredients | Injection, SolutionIntravenous | 65219-151 | 65219-0151-75 | — |
| Potassium Chloride in Dextrose and Sodium Chloridedextrose monohydrate, sodium chloride, and potassium chloride | Dextrose monohydrate 50 g/1000mL + 2 more ingredients | Injection, SolutionIntravenous | 65219-153 | 65219-0153-10 | — |
| Potassium Chloride in Dextrose and Sodium Chloridedextrose monohydrate, sodium chloride, and potassium chloride | Dextrose monohydrate 50 g/1000mL + 2 more ingredients | Injection, SolutionIntravenous | 65219-118 | 65219-0118-10 | — |
| Potassium Chloride in Dextrose and Sodium Chloridedextrose monohydrate, sodium chloride, and potassium chloride | Dextrose monohydrate 50 g/1000mL + 2 more ingredients | Injection, SolutionIntravenous | 65219-119 | 65219-0119-10 | — |
| Potassium Chloride in Dextrose and Sodium Chloridedextrose monohydrate, sodium chloride, and potassium chloride | Dextrose monohydrate 50 g/1000mL + 2 more ingredients | Injection, SolutionIntravenous | 65219-142 | 65219-0142-10 | — |
| Potassium Chloride in Dextrose and Sodium Chloridedextrose monohydrate, sodium chloride, and potassium chloride | Dextrose monohydrate 50 g/1000mL + 2 more ingredients | Injection, SolutionIntravenous | 65219-144 | 65219-0144-10 | — |
| Potassium Chloride in Dextrose and Sodium Chloridedextrose monohydrate, sodium chloride, and potassium chloride | Dextrose monohydrate 50 g/1000mL + 2 more ingredients | Injection, SolutionIntravenous | 65219-146 | 65219-0146-10 | — |
| Potassium Chloride in Dextrose and Sodium Chloridedextrose monohydrate, sodium chloride, and potassium chloride | Dextrose monohydrate 50 g/1000mL + 2 more ingredients | Injection, SolutionIntravenous | 65219-148 | 65219-0148-10 | — |
| Potassium Chloride in Dextrose and Sodium Chloridedextrose monohydrate, sodium chloride, and potassium chloride | Dextrose monohydrate 25 g/500mL + 2 more ingredients | Injection, SolutionIntravenous | 65219-150 | 65219-0150-75 | — |
| Lacosamide | Lacosamide 10 mg/mL | InjectionIntravenous | 65219-204 | 65219-0204-20 | — |
| Iodixanol | Iodixanol 270 mg/mL | Injection, SolutionIntravascular | 65219-381 | 65219-0381-1065219-0381-50 | — |
| Iodixanol | Iodixanol 320 mg/mL | Injection, SolutionIntravascular | 65219-383 | 65219-0383-0565219-0383-1065219-0383-50+1 more | — |
| Gadoterate Meglumine | Gadoterate meglumine 376.9 mg/mL | InjectionIntravenous | 65219-082 | 65219-0082-10 | — |
| Gadoterate Meglumine | Gadoterate meglumine 376.9 mg/mL | InjectionIntravenous | 65219-084 | 65219-0084-15 | — |
| Gadoterate Meglumine | Gadoterate meglumine 376.9 mg/mL | InjectionIntravenous | 65219-086 | 65219-0086-20 | — |
| Gadoterate Meglumine | Gadoterate meglumine 376.9 mg/mL | InjectionIntravenous | 65219-088 | 65219-0088-50 | — |
| Gadoterate Meglumine | Gadoterate meglumine 376.9 mg/mL | InjectionIntravenous | 65219-080 | 65219-0080-05 | — |
| Cardioplegic Solutionpotassium chloride, sodium chloride, calcium chloride, and magnesium chloride | Potassium chloride 119.3 mg/100mL + 3 more ingredients | Injection, SolutionIntra-arterial | 65219-258 | 65219-0258-10 | — |
| Ondansetronondansetron hydrochloride | Ondansetron hydrochloride 4 mg/2mL | Injection, SolutionIntramuscular, Intravenous | 76045-216 | 76045-0216-20 | J2405 |
| Pemetrexedpemetrexed disodium | Pemetrexed disodium 750 mg/30mL | Injection, Powder, Lyophilized, For solutionIntravenous | 63323-621 | 63323-0621-00 | — |
| Pemetrexedpemetrexed disodium | Pemetrexed disodium 1 g/40mL | Injection, Powder, Lyophilized, For solutionIntravenous | 63323-622 | 63323-0622-00 | — |
| Pemetrexedpemetrexed disodium | Pemetrexed disodium 500 mg/20mL | Injection, Powder, Lyophilized, For solutionIntravenous | 63323-450 | 63323-0450-50 | — |
| Pemetrexedpemetrexed disodium | Pemetrexed disodium 100 mg/4mL | Injection, Powder, Lyophilized, For solutionIntravenous | 63323-134 | 63323-0134-10 | — |
| Bortezomib | Bortezomib 3.5 mg/1 | Injection, Powder, Lyophilized, For solutionIntravenous, Subcutaneous | 63323-821 | 63323-0821-10 | — |
| Sterile Waterwater | Water 1 mL/mL | InjectionIntramuscular, Intravenous, Subcutaneous | 65219-187 | 65219-0187-10 | — |
| Glycopyrrolate | Glycopyrrolate .2 mg/mL | InjectionIntramuscular, Intravenous | 76045-023 | 76045-0023-30 | — |
| Glycopyrrolate | Glycopyrrolate .2 mg/mL | InjectionIntramuscular, Intravenous | 76045-223 | 76045-0223-30 | — |
| Thiotepa | Thiotepa 100 mg/1 | Injection, Powder, Lyophilized, For solutionIntracavitary, Intravenous, Intravesical | 65219-029 | 65219-0029-20 | — |
| Sodium Phosphatessodium phosphate, monobasic, monohydrate and sodium phosphate, dibasic, anhydrous | Sodium phosphate, Monobasic, Monohydrate 276 mg/mL; Sodium phosphate, Dibasic, Anhydrous 142 mg/mL | Injection, SolutionIntravenous | 63323-881 | 63323-0881-16 | — |
Fresenius Kabi USA, LLC: common questions
- What is Fresenius Kabi USA, LLC's NDC labeler code?
- 63323, 65219, 76045. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Fresenius Kabi USA, LLC?
- Med-Code's HCPCS directory matches J3357, J0897, J0171 to these products. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.